Tirzepatide
US$ 23.12
tirzepatide $99 GLP-2 TRZ Tirzepatide 10mg — GLP-1/GIP Dual-Agonist
Description
Individual results depend on starting weight, dose, consistency, and daily habits
Researchers also identified a dose response, meaning that the longer the patients took a GLP-1, the more likely they were to develop the condition
It is important to note that these impressive amounts of weight loss occurred over 72 weeks of treatment
C., & Vissers, M
This dual action helps maintain blood sugar levels within a normal range, reducing the risk of hyperglycemia
